ArticleScientific reports2025
Cerebrovascular complications in pediatric patients with acute lymphoblastic leukemia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Health-Related Quality of Life in Children with Acute Leukaemia and Central Nervous System Tumours: Current Evidence and Future Directions.Children (Basel, Switzerland) · 2026Review
- Prolonged Headache in a 13-Year-Old Girl With Acute Lymphoblastic Leukemia: A Case of Possible Neuroinflammatory Complication Responsive to Intravenous Immunoglobulin.Clinical case reports · 2026Article
- Molecular and Mechanistic Divergence of Seizures in Pediatric Acute Lymphoblastic Leukemia: CNS Infiltration Versus Chemotherapy-Induced Neurotoxicity.International journal of molecular sciences · 2026Review
- Radiological Findings and Genetic Rearrangements in Paediatric Patients with Acute Lymphoblastic Leukaemia.The application of clinical genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with central nervous system (CNS) complications occurring in approximately 10% of cases. This study aimed to analyze cerebrovascular complications in pediatric ALL patients. We conducted a retrospective analysis of 144 pediatric ALL patients treated at the University Children's Hospital in Lublin from 2014 to 2023. Statistical analyses were performed using PQStat software. Among the patients, 12.5% (n = 18) developed cerebrovascular complications, with equal distribution between genders. The median age was 6.3 years. Most complications (83.3%) occurred during induction therapy. The most frequent symptom was seizures (50%), followed by impaired consciousness (39%). Magnetic resonance imaging (MRI) detected ischemic complications in 44.4% of affected patients. No significant correlation was found between risk group, diagnostic parameters, or gender and CNS complications. CNS complications, particularly seizures and ischemic events, are common in pediatric ALL, primarily during induction therapy. MRI plays a crucial role in early detection. Further multicenter studies are necessary to improve management and reduce treatment-related neurotoxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.